Accelerate progression of your hit series to leads through in-silico analysis
AI/Virtual screening as an in-silico analysis for hit analogs, structure activity relationships and docking studies In addition to (ultra-)High Throughput
Ultra-High Throughput Hit Discovery against Protein-Protein interactions: A SAR CoV-2 Showcase
Why small-molecule inhibitors of COVID-19? Large health and economic damage Limited effect of repurposed antiviral drugs Vaccination stretches beyond 2023
Collaborating with Pivot Park Screening Centre – a testimonial by Odyssey
“Odyssey Therapeutics has recently run a complex, cell-based HTS at Pivot Park Screening Centre. I was particularly impressed by their
Pivot Park Screening Centre joins Shonan Health Innovation Park
Pivot Park Screening Centre has joined the Shonan Health Innovation park (Shonan iPark), a co-location facility for an open innovation
Oss, the Netherlands – 9 March 2023 The project looked for compounds that stop the virus’s spike protein from binding
Assay Development Fund now available for your early drug discovery project
Oss, the Netherlands – 20 February 2023 Pivot Park Screening Centre is excited to take the coordinating role in this
Mass Spectrometry methods in High Throughput Screening
Maaike Bras, a former scientist in assay development at Pivot Park Screening Centre, joined in the Lab of the Future
We have been awarded the ISO 9001:2015 & ISO/IEC 27001:2013 certification
Oss, the Netherlands – 4 January 2023 It’s official! After all our hard work we have been awarded the prestigious
Oss, the Netherlands – 9 December 2022 With the world still in the grasp of continued Covid-19 infections and the
Pivot Park Screening Centre (PPSC) celebrates its 10-year anniversary
Oss, the Netherlands – 15 November 2022 Today Pivot Park Screening Centre celebrates its 10-year anniversary. PPSC builds on the
Growth Fund invests 325 million euros in Oncode-PACT to accelerate the development of cancer drugs
Utrecht, 14 April 2022 – The National Growth Fund invests 325 million euros in the Oncode-PACT plan to accelerate the preclinical
Label-free Mass Spectrometry ultra-HighThroughput Screening
A game-changer in small molecule lead discovery. Pivot Park Screening Centre (PPSC) is the first contract research organization (CRO) that
Pivot Park – Banting Building (RE600)
Kloosterstraat 9
5349 AB Oss
The Netherlands
Pivot Park Screening Centre
Building OP
Kloosterstraat 9
5349 AB Oss
The Netherlands
